Zobrazeno 1 - 10
of 30
pro vyhledávání: '"David, Sherris"'
Autor:
Laura E. Benjamin, David Sherris, Durga Udayakumar, Carole Perruzzi, Benjamin Hopkins, Qi Xue
Supplementary Figure 1 from Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2b91d56976acc2b768b6f4f62f6462
https://doi.org/10.1158/0008-5472.22376649.v1
https://doi.org/10.1158/0008-5472.22376649.v1
Publikováno v:
Nasal Physiology and Pathophysiology of Nasal Disorders ISBN: 9783031123856
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c7e55e5ff7f7b90bbf141aa9023555
https://doi.org/10.1007/978-3-031-12386-3_9
https://doi.org/10.1007/978-3-031-12386-3_9
Publikováno v:
Molecules, Vol 23, Iss 7, p 1615 (2018)
Discovery of inhibitors for endothelial-related transcription factors can contribute to the development of anti-angiogenic therapies that treat various diseases, including cancer. The role of transcription factor Vezf1 in vascular development and reg
Externí odkaz:
https://doaj.org/article/3bd977948705422e947f1622f9dc918e
Autor:
Jorge L. Jacot, David Sherris
Publikováno v:
Journal of Ophthalmology, Vol 2011 (2011)
Novel therapeutics such as inhibitors of PI3K/Akt/mTOR pathway presents a unique opportunity for the management of diabetic retinopathy (DR). Second generation mTOR inhibitors have the prospect to be efficacious in managing various stages of disease
Externí odkaz:
https://doaj.org/article/54d0c2d2cdfc407182314220526d7675
Autor:
Nathan Sandbo, Keith T. Ferguson, Ksenija Bernau, David Sherris, Elizabeth E. Torr, Jonathan P Leet
Publikováno v:
Journal of Cellular Biochemistry. 118:2241-2249
Idiopathic pulmonary fibrosis is a progressive and deadly disorder with very few therapeutic options. Palomid 529 (8-(1-hydroxyethyl)-2-methoxy-3-(4-methoxybenzyloxy)-benzo[c]chromen-6-one; P529) is a novel dual inhibitor of mechanistic target of rap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4179680b89c1cce4a4b65bfcd818f397
https://doi.org/10.1002/jcb.25878
https://doi.org/10.1002/jcb.25878
Autor:
Francesco Marampon, Andrea Mancini, Flora Vitale, Giovanni Luca Gravina, Stefano Martellucci, Vincenzo Mattei, Simona Pompili, Claudio Festuccia, Leda Biordi, Simona Delle Monache, David Sherris, Roberta Sferra, Alessandro Colapietro
Publikováno v:
Cancers, Vol 11, Iss 10, p 1604 (2019)
Cancers
Volume 11
Issue 10
Cancers
Volume 11
Issue 10
Background. Glioblastoma multiforme (GBM) is a devastating disease showing a very poor prognosis. New therapeutic approaches are needed to improve survival and quality of life. GBM is a highly vascularized tumor and as such, chemotherapy and anti-ang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee621de376289bf9c588e851612fe48d
http://hdl.handle.net/11573/1361371
http://hdl.handle.net/11573/1361371
Publikováno v:
Molecules, Vol 23, Iss 7, p 1615 (2018)
Molecules
Volume 23
Issue 7
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules
Volume 23
Issue 7
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Discovery of inhibitors for endothelial-related transcription factors can contribute to the development of anti-angiogenic therapies that treat various diseases, including cancer. The role of transcription factor Vezf1 in vascular development and reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80e613383cf8abade7e5566987cbaf8
http://www.mdpi.com/1420-3049/23/7/1615
http://www.mdpi.com/1420-3049/23/7/1615
Autor:
F. Vittorini, Emmanuele A. Jannini, Giovanni Luca Gravina, David Sherris, Vincenzo Tombolini, Andrea Lenzi, Claudio Festuccia, Ernesto Di Cesare, Francesco Marampon
Publikováno v:
The Prostate. 74:852-868
BACKGROUND P529, a Torc1/Torc2 inhibitor, has demonstrated its potential as a radiosensitizer. However the molecular mechanisms underlying this phenomenon still need to be elucidated. Aim of this study is to dissect molecular mechanisms regulating th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac287ee9a2f6fbf53b69ea30d455822f
https://doi.org/10.1002/pros.22804
https://doi.org/10.1002/pros.22804
Publikováno v:
International Journal of Cancer. 133:1222-1233
Palomid 529, a novel dual mTORC1/2 inhibitor has displayed interesting activities in experimental models and is a candidate for clinical evaluation. We have assessed the interaction of Palomid 529 with ATP-binding cassette (ABC) drug efflux transport
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4de0593aa099822949ba8ed106b12b83
https://doi.org/10.1002/ijc.28126
https://doi.org/10.1002/ijc.28126
Publikováno v:
Journal of Chromatography B. 879:3823-3831
Palomid 529 (8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[ c ]chromen-6-one), is a novel non-steroidal small-molecule drug, which inhibits both mTORC1 and mTORC2 assembly, and elicits both anti-angiogenic and direct anti-tumor effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6053bab373a756434ba8185afcd0c46d
https://doi.org/10.1016/j.jchromb.2011.10.028
https://doi.org/10.1016/j.jchromb.2011.10.028